Francesca Rapino is FNRS and WELBIO investigator at the University of Liege, director of the Lab of cancer stemness at GIGA-Research Institute. She has made key discoveries in the field of tRNA epitrancriptomics and cancer and her lab is now focusing on the priming role of tRNAs in differentiation and cancer stem cells establishment. After training in Molecular Biology at the University of Tor Vergata (Rome, Italy), she obtained a PhD in Molecular Pharmacy at the Goethe University (Frankfurt am Main, Germany) and then join the University of Liege for her post-doc. She has been awarded of several national and international prizes such as the King Baudouin Foundation award for biochemical research on cancer, and of competitive grants to support her work, (Welbio, Foundation against cancer). She has also been awarded of the ERC starting grant in 2020. In 2022, she co-founded the spin off THERAtRAME where she acts as Chief Operating Officer.
Francesca will be presenting at the State of the Union on 31 May.